BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 23770250)

  • 21. Anti-HLA-A, -B, -DR, -DQB1 and -DQA1 antibodies reactive epitope determination with HLAMatchmaker in multipare awaiting list for heart transplant.
    Resse M; Paolillo R; Casamassimi A; Cavalca F; Fiorito C; Maiello C; Napoli C
    Hum Immunol; 2013 Aug; 74(8):937-41. PubMed ID: 23628396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First report on the antibody verification of MICA epitopes recorded in the HLA epitope registry.
    Duquesnoy RJ; Mostecki J; Marrari M; da Silva AS; da Mata Sousa LC; do Monte SJ
    Int J Immunogenet; 2014 Oct; 41(5):370-7. PubMed ID: 25053277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structurally based epitope analysis of major histocompatibility complex class I-related chain A (MICA) antibody specificity patterns.
    Duquesnoy RJ; Mostecki J; Hariharan J; Balazs I
    Hum Immunol; 2008 Dec; 69(12):826-32. PubMed ID: 18957310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of weak/non-complement-binding HLA antibodies on C1q-binding.
    Hönger G; Amico P; Arnold ML; Spriewald BM; Schaub S
    HLA; 2017 Aug; 90(2):88-94. PubMed ID: 28585289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody-reactive class I epitopes defined by pairs of mismatched eplets and self-eplets.
    Resse M; Paolillo R; Minucci BP; Moccia G; Napoli C
    Tissue Antigens; 2015 Nov; 86(5):368-72. PubMed ID: 26373475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Comprehensive Evaluation of the Antibody-Verified Status of Eplets Listed in the HLA Epitope Registry.
    Bezstarosti S; Bakker KH; Kramer CSM; de Fijter JW; Reinders MEJ; Mulder A; Claas FHJ; Heidt S
    Front Immunol; 2021; 12():800946. PubMed ID: 35154076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA (A*0201) mimicry by anti-idiotypic monoclonal antibodies.
    Burlingham WJ; Jankowska-Gan E; DeVito-Haynes L; Fechner JH; Hogan KT; Claas FH; Mulder A; Wang X; Ferrone S
    J Immunol; 1998 Dec; 161(12):6705-14. PubMed ID: 9862700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 16th IHIW: a website for antibody-defined HLA epitope Registry.
    Duquesnoy RJ; Marrari M; da M Sousa LC; de M Barroso JR; de S U Aita KM; da Silva AS; do Monte SJ
    Int J Immunogenet; 2013 Feb; 40(1):54-9. PubMed ID: 23136897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization.
    Ata P; Canbakan M; Kara M; Özel L; Ünal E; Titiz Mİ
    Transplant Proc; 2012; 44(6):1652-5. PubMed ID: 22841237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: relevance to human natural HLA antibodies.
    Ravindranath MH; Taniguchi M; Chen CW; Ozawa M; Kaneku H; El-Awar N; Cai J; Terasaki PI
    Mol Immunol; 2010 Feb; 47(5):1121-31. PubMed ID: 19944464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3.
    Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1988 Oct; 141(7):2519-25. PubMed ID: 2459215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological functions of C1q expressed by conformational changes.
    Heinz HP
    Behring Inst Mitt; 1989 Jul; (84):20-31. PubMed ID: 2478117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C1q-binding anti-HLA antibodies do not predict platelet transfusion failure in Trial to Reduce Alloimmunization to Platelets study participants.
    Jackman RP; Lee JH; Pei R; Bolgiano D; Lebedeva M; Slichter SJ; Norris PJ
    Transfusion; 2016 Jun; 56(6):1442-50. PubMed ID: 27079754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production and characterization of chimeric anti-HLA monoclonal antibodies targeting public epitopes as tools for standardizations of the anti-HLA antibody detection.
    Congy-Jolivet N; Drocourt D; Portet S; Tiraby G; Blancher A
    J Immunol Methods; 2013 Apr; 390(1-2):41-51. PubMed ID: 23352853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies.
    Bindon CI; Hale G; Waldmann H
    Eur J Immunol; 1988 Oct; 18(10):1507-14. PubMed ID: 2973413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C1q A08 Is a Half-Cryptic Epitope of Anti-C1q A08 Antibodies in Lupus Nephritis and Important for the Activation of Complement Classical Pathway.
    Wu WJ; Tan Y; Liu XL; Yu F; Zhao MH
    Front Immunol; 2020; 11():848. PubMed ID: 32536911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgG pair formation on one antigenic molecule is the main mechanism of synergy between antibodies in complement-mediated lysis.
    Hughes-Jones NC; Gorick BD; Miller NG; Howard JC
    Eur J Immunol; 1984 Nov; 14(11):974-8. PubMed ID: 6209148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLAMatchmaker-based definition of structural human leukocyte antigen epitopes detected by alloantibodies.
    Duquesnoy RJ; Marrari M
    Curr Opin Organ Transplant; 2009 Aug; 14(4):403-9. PubMed ID: 19417654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New HLA class I epitopes defined by murine monoclonal antibodies.
    El-Awar N; Terasaki PI; Nguyen A; Lias M; Conger N
    Hum Immunol; 2010 May; 71(5):456-61. PubMed ID: 20156507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune complex mediated activation of the classical complement pathway.
    Borsos T
    Behring Inst Mitt; 1989 Jul; (84):93-101. PubMed ID: 2478118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.